Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

Clinical trial NCT04160455 · RECRUITING

Trial details

NCT number: NCT04160455
Sponsor: Centre Hospitalier Régional d'Orléans
Status: RECRUITING
Study type: OBSERVATIONAL

Autophagy Galectins HIV Infections Highly Active Antiretroviral Therapy

Start date: 2019-11-07
Primary completion: 2029-11-07
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.